Filing Details
- Accession Number:
- 0001807094-20-000005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-04 21:55:17
- Reporting Period:
- 2020-04-30
- Accepted Time:
- 2020-05-04 21:55:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1175680 | Cytodyn Inc. | CYDY | Pharmaceutical Preparations (2834) | 753056237 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1532878 | Nader Pourhassan | 1111 Main Street, Suite 660 Vancouver WA 98660 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-04-30 | 200,000 | $0.90 | 517,417 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-04-30 | 325,000 | $0.87 | 842,417 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-04-30 | 152,000 | $0.75 | 994,417 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-04-30 | 600,000 | $1.09 | 1,594,417 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-04-30 | 199,800 | $0.57 | 1,794,217 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-04-30 | 600,000 | $0.80 | 2,394,217 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-04-30 | 116,550 | $0.49 | 2,510,767 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-04-30 | 1,000,000 | $0.57 | 3,510,767 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-04-30 | 187,817 | $0.39 | 3,698,584 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-04-30 | 2,000,000 | $0.63 | 5,698,584 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-04-30 | 2,219,837 | $3.53 | 3,478,747 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-01 | 1,399,685 | $3.26 | 2,079,062 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-05-04 | 30,933 | $0.39 | 2,109,995 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-05-04 | 1,201,652 | $2.79 | 908,343 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option | Acquisiton | 2020-04-30 | 150,000 | $0.00 | 150,000 | $0.90 |
| Common Stock | Employee Stock Option | Acquisiton | 2020-04-30 | 325,000 | $0.00 | 325,000 | $0.87 |
| Common Stock | Employee Stock Option | Acquisiton | 2020-04-30 | 152,000 | $0.00 | 152,000 | $0.75 |
| Common Stock | Employee Stock Option | Acquisiton | 2020-04-30 | 600,000 | $0.00 | 600,000 | $1.09 |
| Common Stock | Employee Stock Option | Acquisiton | 2020-04-30 | 199,800 | $0.00 | 199,800 | $0.57 |
| Common Stock | Employee Stock Option | Acquisiton | 2020-04-30 | 50,000 | $0.00 | 50,000 | $0.90 |
| Common Stock | Employee Stock Option | Acquisiton | 2020-04-30 | 600,000 | $0.00 | 600,000 | $0.80 |
| Common Stock | Employee Stock Option | Acquisiton | 2020-04-30 | 116,550 | $0.00 | 116,550 | $0.49 |
| Common Stock | Employee Stock Option | Acquisiton | 2020-04-30 | 1,000,000 | $0.00 | 1,000,000 | $0.57 |
| Common Stock | Employee Stock Option | Acquisiton | 2020-04-30 | 187,817 | $0.00 | 187,817 | $0.39 |
| Common Stock | Employee Stock Option | Acquisiton | 2020-04-30 | 2,000,000 | $0.00 | 2,000,000 | $0.63 |
| Common Stock | Employee Stock Option | Acquisiton | 2020-05-04 | 30,933 | $0.00 | 30,933 | $0.39 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-06-30 | 2025-06-30 | No | 4 | M | Direct |
| 0 | 2015-11-23 | 2025-11-23 | No | 4 | M | Direct |
| 0 | 2016-01-04 | 2026-01-04 | No | 4 | M | Direct |
| 0 | 2019-06-01 | 2026-06-01 | No | 4 | M | Direct |
| 100,200 | 2019-06-01 | 2027-06-01 | No | 4 | M | Direct |
| 0 | 2019-06-18 | 2029-06-18 | No | 4 | M | Direct |
| 0 | 2018-02-15 | 2023-02-15 | No | 4 | M | Direct |
| 233,450 | 2019-06-08 | 2028-06-08 | No | 4 | M | Direct |
| 0 | 2019-04-08 | 2028-11-08 | No | 4 | M | Direct |
| 187,183 | 2019-04-07 | 2029-10-07 | No | 4 | M | Direct |
| 0 | 2019-12-19 | 2029-12-19 | No | 4 | M | Direct |
| 156,250 | 2019-10-07 | 2029-10-07 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 15,570 | Indirect | By Spouse |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $3.44 to $3.74. The price above reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $3.13 to $3.54. The price above reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $2.53 to $3.00. The price above reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- Option grant vests over a three year period beginning June 1, 2018.
- Option grant vests over a three year period beginning June 8, 2019.
- Option grant vests in equal monthly installments over a 12-month period beginning October 7, 2019.
Billionaire Hedge Funds
